Hyperlipidemia May Heighten Breast Cancer Risk

Share this content:
Hyperlipidemia May Heighten Breast Cancer Risk
Hyperlipidemia May Heighten Breast Cancer Risk

(HealthDay News) -- Women with hyperlipidemia have an increased risk of developing breast cancer, according to a study presented at the European Society of Cardiology's Frontiers in CardioVascular Biology 2014 in Barcelona, Spain.

Rahul Potluri, MBBS, from Aston University in Birmingham, U.K., and colleagues examined the risk of breast cancer among patients with and without hyperlipidemia in the Algorithm for Comorbidities, Associations, Length of stay and Mortality study population. Of the 664,159 women, 22,938 patients (3.5%) had hyperlipidemia and 9,312 had breast cancer.

RELATED: Breast Cancer Resource Center

The researchers found that 2.3% of the patients with hyperlipidemia had breast cancer, compared with 1.4% of those without hyperlipidemia. The presence of hyperlipidemia was associated with a 1.64-fold increase in the risk of having breast cancer, after accounting for the time from first presentation to development of breast cancer.

"Our preliminary study suggests that women with high cholesterol in their blood may be at greater risk of getting breast cancer," Potluri said in a statement. "It raises the possibility of preventing breast cancer with statins, which lower cholesterol, but as this is a primitive study, significant time and research is needed before this idea can be tested."

Related Resources

Related Slideshows

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs